placebo to aprepitant

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Post-operative NauseaPost-operative VomitingVomiting

Phase 2

A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219)

CompletedNCT01732458

Merck Sharp & Dohme LLCPost-operative Nausea, Post-operative Vomiting

Start: 2013-02-12End: 2016-09-26Updated: 2018-09-25

Phase 3

Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)

CompletedNCT00080444

Merck Sharp & Dohme LLCVomiting

Start: 2004-04-30End: 2007-03-31Updated: 2014-08-05

Related Papers

Pharmacokinetics and pharmacodynamics of aprepitant for the prevention of postoperative nausea and vomiting in pediatric subjects.

2018-09-219 citations